ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

Pharmaceutical Quality and Bioequivalence Assessment of Generic Mycophenolate Mofetil Tablets

W. Jiang, R. Lionberger, J. Li, Y. Peng, L. Yu

Office of Generic Drugs, FDA, Rockville

Meeting: 2013 American Transplant Congress

Abstract number: 418

Related Abstracts
  • Phase 3, Double-Blind, Multi-Center, Non-Inferiority, Randomized Study To Examine the Efficacy and Safety of LCP-Tacro™ Tablets, Once Daily, Compared to Prograf® Capsules, Twice Daily, in Combination with Mycophenolate Mofetil in De Novo Adult Kidney Transplantation: Baseline Characteristics, A
  • Transplant Certification and Quality Assessment: The Effect of Center Data Input Quality

Purpose. Mycophenolate Mofetil (MMF) is the most used immunosuppressant in solid organ transplantation. Concerns have been raised about substitution between brand and generic MMF tablets. We assessed pharmaceutical quality and bioequivalence data of the 11 approved generic MMF tablets to evaluate FDA claims that the generic MMF are therapeutically equivalent to the RLD and substitutions to generic MMF are safe. Methods. The point-estimate T/R ratios of AUC0-t and Cmax under fasting and fed conditions were summarized for the 11 generics. Formulation composition, manufacturing process, impurity profiles, and in vitro dissolution were compared. For 3 generics, the lower bound 95% confidence interval of minimum process performance index (CL-Ppk) for some critical quality attributes (CQAs) of the product was calculated to estimate the consistency of product manufacturing. Higher CL-Ppk value suggests a more robust process. Reports from 2000 to 2011 on MMF in the FDA database of field alerts, product complaints, and recalls were also collected. Results. Of the 11 generic products, the mean point estimates of T/R ratio of AUC0-t and Cmax were 100.3% (92-104%) and 99.8% (94-108%) under fasting conditions, and 98.8% (93-102%) and 94.4% (89-104%) under fed conditions. The formulation composition of the generic products was similar to that of the RLD. The generic MMF tablets were manufactured by wet granulation (5/11), dry granulation (5/11), or direct compression (1/11) processes. Despite differences in the manufacturing process, for all the generics throughout their shelf life, the level of total impurities remained less than 0.5% and assay was in the range of 96-104%. The in vitro dissolution profiles of generic and brand were comparable. The CL-Ppk values of the generics were similar to those of RLD.

CL-Ppk values of MMF tablets
Quality attributes RLD Generic A Generic B Generic C
Assay 0.52 2.13 1.71 2.51
Dissolution at 5 min 0.66 0.85 0.73 1.81
Dissolution at 15 min 1.88 1.86 1.51 1.32
Degradation product F 11.29 5.09 6.93 4.42
Total degradation products 7.38 6.05 12.51 7.06

The FDA database search did not suggest that the efficacy and safety of the generic MMF was compromised. Conclusions. Pre- and post-approval data of generic MMF tablet indicated that all approved generic MMF are well within the FDA bioequivalence and quality requirements, and comparable to Cellcept. Process capability data indicate that there is no significant difference in manufacturing consistency between sampled generics and the RLD.

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Jiang W, Lionberger R, Li J, Peng Y, Yu L. Pharmaceutical Quality and Bioequivalence Assessment of Generic Mycophenolate Mofetil Tablets [abstract]. Am J Transplant. 2013; 13 (suppl 5). https://atcmeetingabstracts.com/abstract/pharmaceutical-quality-and-bioequivalence-assessment-of-generic-mycophenolate-mofetil-tablets/. Accessed January 22, 2021.

« Back to 2013 American Transplant Congress

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Penis Transplantation: First U.S. Experience.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Live Related Kidney Transplant Experience in Abuja, Nigeria – First Eight Cases Ever.
    • Penis Transplantation: First U.S. Experience.
    • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
    • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
    • Evidence of a Clinically Significant Drug-Drug Interaction between Cannabidiol and Tacrolimus: A Case Report
    • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes

    Visit Our Partner Sites

    American Transplant Congress (ATC)

    Visit the official site for the American Transplant Congress »

    American Journal of Transplantation

    The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

    American Society of Transplantation (AST)

    An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

    American Society of Transplant Surgeons (ASTS)

    The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

    Copyright © 2013-2021 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

    Privacy Policy

    loading Cancel
    Post was not sent - check your email addresses!
    Email check failed, please try again
    Sorry, your blog cannot share posts by email.
    This site uses cookies: Find out more.